Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening

Sechin Cho, Karen K. Durfee, Brooks Allen Keel, Leland H. Parks

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Unexplained elevated or low maternal serum alpha-fetoprotein (MSAFP) is reported to indicate adverse perinatal outcome. We designed a prospective matched pair study to gain additional information about the type and frequency of adverse neonatal or maternal outcomes. Subjects were selected from 16,445 women who received second trimester MSAFP screening during the 4.5 year study period. For each unexplained elevated or low subject, a control patient in the second trimester of pregnancy was chosen by matching eight individual traits. After follow-up, 356 pairs were identified for the unexplained low MSAFP group and 139 pairs for the unexplained elevated MSAFP group. Outcome information was obtained by way of a physician questionnaire. For the unexplained low MSAFP group, complications occurred no more often than for the paired controls and these pregnancies may not be considered at high risk for adverse outcome. Our study supports a strong association between unexplained elevated MSAFP and adverse neonatal outcomes of low birth weight, fetal death, preterm delivery, acid fetal growth retardation. The highest frequency of adverse neonatal outcome occurred when the multiple of median value was ≤ 4.0. Our study does not support an association between elevated MSAFP and maternal complications of hypertensive disorder, oligohydramnios, or placental abruption.

Original languageEnglish (US)
Pages (from-to)476-483
Number of pages8
JournalJournal of Perinatal Medicine
Volume25
Issue number6
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

alpha-Fetoproteins
Mothers
Pregnancy
Serum
Second Pregnancy Trimester
Oligohydramnios
Abruptio Placentae
Fetal Death
Fetal Growth Retardation
Low Birth Weight Infant
Physicians
Acids

Keywords

  • AFP
  • Alpha fetoprotein
  • Genetic counseling
  • Maternal serum screening
  • Pregnancy complications
  • Pregnancy outcome
  • Prenatal diagnosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening. / Cho, Sechin; Durfee, Karen K.; Keel, Brooks Allen; Parks, Leland H.

In: Journal of Perinatal Medicine, Vol. 25, No. 6, 01.01.1997, p. 476-483.

Research output: Contribution to journalArticle

@article{c63c7c13e7d448d38d58cc2650208358,
title = "Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening",
abstract = "Unexplained elevated or low maternal serum alpha-fetoprotein (MSAFP) is reported to indicate adverse perinatal outcome. We designed a prospective matched pair study to gain additional information about the type and frequency of adverse neonatal or maternal outcomes. Subjects were selected from 16,445 women who received second trimester MSAFP screening during the 4.5 year study period. For each unexplained elevated or low subject, a control patient in the second trimester of pregnancy was chosen by matching eight individual traits. After follow-up, 356 pairs were identified for the unexplained low MSAFP group and 139 pairs for the unexplained elevated MSAFP group. Outcome information was obtained by way of a physician questionnaire. For the unexplained low MSAFP group, complications occurred no more often than for the paired controls and these pregnancies may not be considered at high risk for adverse outcome. Our study supports a strong association between unexplained elevated MSAFP and adverse neonatal outcomes of low birth weight, fetal death, preterm delivery, acid fetal growth retardation. The highest frequency of adverse neonatal outcome occurred when the multiple of median value was ≤ 4.0. Our study does not support an association between elevated MSAFP and maternal complications of hypertensive disorder, oligohydramnios, or placental abruption.",
keywords = "AFP, Alpha fetoprotein, Genetic counseling, Maternal serum screening, Pregnancy complications, Pregnancy outcome, Prenatal diagnosis",
author = "Sechin Cho and Durfee, {Karen K.} and Keel, {Brooks Allen} and Parks, {Leland H.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1515/jpme.1997.25.6.476",
language = "English (US)",
volume = "25",
pages = "476--483",
journal = "Journal of Perinatal Medicine",
issn = "0300-5577",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "6",

}

TY - JOUR

T1 - Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening

AU - Cho, Sechin

AU - Durfee, Karen K.

AU - Keel, Brooks Allen

AU - Parks, Leland H.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Unexplained elevated or low maternal serum alpha-fetoprotein (MSAFP) is reported to indicate adverse perinatal outcome. We designed a prospective matched pair study to gain additional information about the type and frequency of adverse neonatal or maternal outcomes. Subjects were selected from 16,445 women who received second trimester MSAFP screening during the 4.5 year study period. For each unexplained elevated or low subject, a control patient in the second trimester of pregnancy was chosen by matching eight individual traits. After follow-up, 356 pairs were identified for the unexplained low MSAFP group and 139 pairs for the unexplained elevated MSAFP group. Outcome information was obtained by way of a physician questionnaire. For the unexplained low MSAFP group, complications occurred no more often than for the paired controls and these pregnancies may not be considered at high risk for adverse outcome. Our study supports a strong association between unexplained elevated MSAFP and adverse neonatal outcomes of low birth weight, fetal death, preterm delivery, acid fetal growth retardation. The highest frequency of adverse neonatal outcome occurred when the multiple of median value was ≤ 4.0. Our study does not support an association between elevated MSAFP and maternal complications of hypertensive disorder, oligohydramnios, or placental abruption.

AB - Unexplained elevated or low maternal serum alpha-fetoprotein (MSAFP) is reported to indicate adverse perinatal outcome. We designed a prospective matched pair study to gain additional information about the type and frequency of adverse neonatal or maternal outcomes. Subjects were selected from 16,445 women who received second trimester MSAFP screening during the 4.5 year study period. For each unexplained elevated or low subject, a control patient in the second trimester of pregnancy was chosen by matching eight individual traits. After follow-up, 356 pairs were identified for the unexplained low MSAFP group and 139 pairs for the unexplained elevated MSAFP group. Outcome information was obtained by way of a physician questionnaire. For the unexplained low MSAFP group, complications occurred no more often than for the paired controls and these pregnancies may not be considered at high risk for adverse outcome. Our study supports a strong association between unexplained elevated MSAFP and adverse neonatal outcomes of low birth weight, fetal death, preterm delivery, acid fetal growth retardation. The highest frequency of adverse neonatal outcome occurred when the multiple of median value was ≤ 4.0. Our study does not support an association between elevated MSAFP and maternal complications of hypertensive disorder, oligohydramnios, or placental abruption.

KW - AFP

KW - Alpha fetoprotein

KW - Genetic counseling

KW - Maternal serum screening

KW - Pregnancy complications

KW - Pregnancy outcome

KW - Prenatal diagnosis

UR - http://www.scopus.com/inward/record.url?scp=0031468334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031468334&partnerID=8YFLogxK

U2 - 10.1515/jpme.1997.25.6.476

DO - 10.1515/jpme.1997.25.6.476

M3 - Article

VL - 25

SP - 476

EP - 483

JO - Journal of Perinatal Medicine

JF - Journal of Perinatal Medicine

SN - 0300-5577

IS - 6

ER -